RECRUITING
I'm interested ...!!
Evaluation of Intravenous Fluid Therapy Within Dallas Acute Pancreatitis Protocol
Acute pancreatitis (AP) is a common disease of the gastrointestinal tract that can result in emotional, physical, and financial burdens on the patient.
Conditions:
🦠 Acute Pancreatitis
🗓️ Study Start (Actual) 17 July 2023
🗓️ Primary Completion (Estimated) 17 July 2024
✅ Study Completion (Estimated) 17 July 2024
👥 Enrollment (Estimated) 500
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Dallas, Texas, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * ● Age \> 18 years
    • * Diagnosis of AP based on International Statistical Classification of Diseases( ICD)-10 code

    Exclusion Criteria:

    • * ● Diagnosis of chronic pancreatitis
    • * Patients who did not follow the IVF infusion protocol
    • * Received \< 24 hours of IVF therapy
    • * Transferred from another institution
Ages Eligible for Study: 18 Years to 75 Years (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 13 November 2023
  • First Submitted that Met QC Criteria 16 January 2024
  • First Posted 25 January 2024

Study Record Updates

  • Last Update Submitted that Met QC Criteria 16 January 2024
  • Last Update Posted 25 January 2024
  • Last Verified January 2024
I'm interested ...!!